Stay up-to-date on the advancing field of HCT with short summaries and links to the most relevant published research.
A safe and effective shared care approach after allogeneic HCT could be a new standard of care
Maakaron JE, et al. – Research published in Bone Marrow Transplantation suggests that age alone should not be a deciding factor when determining candidacy for transplant in adult patients with acute myeloid leukemia (AML), and transplant should be considered a standard of care option for patients of all ages with AML in first complete remission. This study showed that all age groups reached comparable 3-year overall survival, and differences between younger and older groups were better explained by comorbidities and other factors than age.
Subscribe to E-News
Receive new research summaries monthly.